FZ
Publicaties op Oncologisch.com
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endom...
Pembrolizumab plus CRT bij cervixcarcinoom: ENGOT-cx11/KEYNOTE-A18 OS update
Pembrolizumab plus chemoradiatie bij cervixcarcinoom: ENGOT-cx11/GOG-3047/KEYNOTE-A18 fase III
T-DXd versus physician's choice bij HER2-positief mammacarcinoom: DESTINY-Breast02 fase III
Trastuzumab deruxtecan bij eerder behandeld HER2-laag mammacarcinoom: DESTINY-Breast04 fase III